Name of Fund: |
Fund Address: | 100 Bellevue Parkway, Wilmington, DE 19809 |
2024 Semi-Annual Report (Unaudited) |
BlackRock Core Bond Trust (BHK) |
BlackRock Corporate High Yield Fund, Inc. (HYT) |
BlackRock Credit Allocation Income Trust (BTZ) |
BlackRock Floating Rate Income Trust (BGT) |
Not FDIC Insured • May Lose Value • No Bank Guarantee |
Total Cumulative Distributions for the Fiscal Period |
% Breakdown of the Total Cumulative Distributions for the Fiscal Period | ||||||||||
Trust Name |
Net Income |
Net Realized Capital Gains Short-Term |
Net Realized Capital Gains Long-Term |
Return of Capital (a) |
Total Per Common Share |
Net Income |
Net Realized Capital Gains Short-Term |
Net Realized Capital Gains Long-Term |
Return of Capital |
Total Per Common Share | |
BHK |
$ 0.291321 |
$ — |
$ — |
$ 0.156279 |
$ 0.447600 |
65 % |
— % |
— % |
35 % |
100 % | |
HYT |
0.382004 |
— |
— |
0.085396 |
0.467400 |
82 |
— |
— |
18 |
100 | |
BTZ |
0.340964 |
— |
— |
0.162436 |
0.503400 |
68 |
— |
— |
32 |
100 | |
BGT |
0.593371 |
— |
— |
0.128309 |
0.721680 |
82 |
— |
— |
18 |
100 |
(a) |
Each Trust estimates that it has distributed more than its net income and net realized capital gains; therefore, a portion of the distribution may be a return of capital. A return of capital may occur, for example, when some or all of the shareholder’s investment in a Trust is returned to the shareholder. A return of capital does not necessarily reflect a Trust’s investment performance and should not be confused with “yield” or “income.” When distributions exceed total return performance, the difference will reduce a Trust’s net asset value per share. |
Trust Name |
Amount Per Common Share |
BHK |
$ 0.074600 |
HYT |
0.077900 |
BTZ |
0.083900 |
BGT |
0.120280 |
Symbol on New York Stock Exchange |
BHK |
Initial Offering Date |
November 27, 2001 |
Current Distribution Rate on Closing Market Price as of June 30, 2024 ($10.65) (a) |
8.41% |
Current Monthly Distribution per Common Share (b) |
$0.074600 |
Current Annualized Distribution per Common Share (b) |
$0.895200 |
Leverage as of June 30, 2024 (c) |
35% |
(a) |
Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate may consist of income, net realized gains and/or a return of capital. Past performance is not an indication of future results. |
(b) |
The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain. |
(c) |
Represents reverse repurchase agreements as a percentage of total managed assets, which is the total assets of the Trust (including any assets attributable to any borrowings) minus the sum of its liabilities (other than borrowings representing financial leverage). Does not reflect derivatives or other instruments that may give rise to economic leverage. For a discussion of leveraging techniques utilized by the Trust, please see The Benefits and Risks of Leveraging and Derivative Financial Instruments. |
06/30/24 |
12/31/23 |
Change |
High |
Low | |
Closing Market Price |
$ 10.65 |
$ 10.91 |
(2.38 ) % |
$ 11.00 |
$ 10.23 |
Net Asset Value |
10.51 |
11.02 |
(4.63 ) |
11.02 |
10.24 |
Average Annual Total Returns | ||||
6-month |
1 Year |
5 Years |
10 Years | |
Trust at NAV (a)(b) |
(0.52 ) % |
4.77 % |
(0.14 ) % |
3.10 % |
Trust at Market Price (a)(b) |
1.82 |
9.06 |
1.42 |
4.05 |
Bloomberg U.S. Credit Index (c) |
(0.46 ) |
4.42 |
0.54 |
2.21 |
Reference Benchmark (d) |
(0.90 ) |
3.30 |
0.23 |
2.28 |
Bloomberg U.S. Long Government/Credit Index (e) |
(4.10 ) |
(1.58 ) |
(2.22 ) |
1.65 |
Bloomberg Intermediate Credit Index (f) |
0.93 |
5.60 |
1.32 |
2.20 |
Bloomberg U.S. Corporate High Yield 2% Issuer Capped Index (g) |
2.58 |
10.43 |
3.90 |
4.30 |
Bloomberg CMBS, Eligible for U.S. Aggregate Index (h) |
1.53 |
5.76 |
0.69 |
1.95 |
Bloomberg MBS Index (i) |
(0.98 ) |
2.12 |
(0.76 ) |
0.89 |
Bloomberg ABS Index (j) |
1.66 |
5.46 |
1.62 |
1.84 |
(a) |
All returns reflect reinvestment of dividends and/or distributions at actual reinvestment prices. Performance results reflect the Trust’s use of leverage, if any. |
(b) |
The Trust moved from a discount to NAV to a premium during the period, which accounts for the difference between performance based on market price and performance based on NAV. |
(c) |
An index that measures the investment grade, U.S. dollar-denominated, fixed-rate, taxable corporate and government related bond markets. It is composed of the U.S. Corporate Index and a non-corporate component that includes foreign agencies, sovereigns, supranationals and local authorities. |
(d) |
The Reference Benchmark is comprised of the Bloomberg U.S. Long Government/Credit Index (40%); Bloomberg Intermediate Credit Index (24%); Bloomberg U.S. Corporate High Yield 2% Issuer Capped Index (16%); Bloomberg CMBS, Eligible for U.S. Aggregate Index (8%); Bloomberg MBS Index (8%); and Bloomberg ABS Index (4%). The Reference Benchmark’s index content and weightings may have varied over past periods. |
(e) |
An unmanaged index that is the long component of the Bloomberg U.S. Government/Credit Index. It includes publicly issued U.S. Treasury debt, U.S. government agency debt, taxable debt issued by U.S. states and territories and their political subdivisions, debt issued by U.S. and non-U.S. corporations, non-U.S. government debt and supranational debt. |
(f) |
An unmanaged index that is the intermediate component of the Bloomberg U.S. Credit Index. The Bloomberg U.S. Credit Index includes publicly issued U.S. corporate and foreign debentures and secured notes that meet specified maturity, liquidity, and quality requirements. |
(g) |
An unmanaged index comprised of issuers that meet the following criteria: at least $150 million par value outstanding; maximum credit rating of Ba1; at least one year to maturity; and no issuer represents more than 2% of the index. |
(h) |
An unmanaged index that is the CMBS component of the Bloomberg U.S. Aggregate Index. |
(i) |
An unmanaged index that is a market value-weighted index, which covers the mortgage-backed securities component of the Bloomberg U.S. Aggregate Bond Index. It is comprised of agency mortgage-backed pass-through securities of the Government National Mortgage Association (Ginnie Mae), the Federal National Mortgage Association (Fannie Mae), and the Federal Home Loan Mortgage Corporation (Freddie Mac) with a minimum $150 million par amount outstanding and a weighted-average maturity of at least 1 year. The index includes reinvestment of income. |
(j) |
An unmanaged index that is the asset-backed securities component of the Bloomberg U.S. Aggregate Index. |
PORTFOLIO COMPOSITION | |
Investment Type |
Percent of Total Investments (a) |
Corporate Bonds |
41.7 % |
U.S. Treasury Obligations |
15.1 |
U.S. Government Sponsored Agency Securities |
12.8 |
Asset-Backed Securities |
10.8 |
Non-Agency Mortgage-Backed Securities |
9.2 |
Preferred Securities |
4.2 |
Municipal Bonds |
2.4 |
Floating Rate Loan Interests |
2.4 |
Foreign Agency Obligations |
1.1 |
Fixed Rate Loan Interests |
0.3 |
CREDIT QUALITY ALLOCATION | |
Credit Rating (b) |
Percent of Total Investments (a) |
AAA/Aaa (c) |
36.1 % |
AA/Aa |
4.4 |
A |
12.7 |
BBB/Baa |
18.4 |
BB/Ba |
9.7 |
B |
10.4 |
CCC/Caa |
2.2 |
CC |
— (d) |
C |
0.2 |
D |
— (d) |
N/R (e) |
5.9 |
(a) |
Excludes short-term securities. |
(b) |
For purposes of this report, credit quality ratings shown above reflect the highest rating assigned by either S&P Global Ratings or Moody’s Investors Service, Inc. if ratings differ. These rating agencies are independent, nationally recognized statistical rating organizations and are widely used. Investment grade ratings are credit ratings of BBB/Baa or higher. Below investment grade ratings are credit ratings of BB/Ba or lower. Investments designated N/R are not rated by either rating agency. Unrated investments do not necessarily indicate low credit quality. Credit quality ratings are subject to change. |
(c) |
The investment adviser evaluates the credit quality of unrated investments based upon certain factors including, but not limited to, credit ratings for similar investments and financial analysis of sectors, individual investments and/or issuers. Using this approach, the investment adviser has deemed unrated U.S. Government Sponsored Agency Securities and U.S. Treasury Obligations to be of similar credit quality as investments rated AAA/Aaa. |
(d) |
Rounds to less than 0.1%. |
(e) |
The investment adviser evaluates the credit quality of unrated investments based upon certain factors including, but not limited to, credit ratings for similar investments and financial analysis of sectors and individual investments. Using this approach, the investment adviser has deemed certain of these unrated securities as investment grade quality. As of June 30, 2024, the market value of unrated securities deemed by the investment adviser to be investment grade represents less than 1.0% of total investments. |
Symbol on New York Stock Exchange |
HYT |
Initial Offering Date |
May 30, 2003 |
Current Distribution Rate on Closing Market Price as of June 30, 2024 ($9.69) (a) |
9.65% |
Current Monthly Distribution per Common Share (b) |
$0.077900 |
Current Annualized Distribution per Common Share (b) |
$0.934800 |
Leverage as of June 30, 2024 (c) |
26% |
(a) |
Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate may consist of income, net realized gains and/or a return of capital. Past performance is not an indication of future results. |
(b) |
The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain. |
(c) |
Represents bank borrowings outstanding as a percentage of total managed assets, which is the total assets of the Trust (including any assets attributable to borrowings), minus the sum of liabilities (other than borrowings representing financial leverage). Does not reflect derivatives or other instruments that may give rise to economic leverage. For a discussion of leveraging techniques utilized by the Trust, please see The Benefits and Risks of Leveraging and Derivative Financial Instruments. |
06/30/24 |
12/31/23 |
Change |
High |
Low | |
Closing Market Price |
$ 9.69 |
$ 9.43 |
2.76 % |
$ 9.93 |
$ 9.26 |
Net Asset Value |
9.60 |
9.73 |
(1.34 ) |
9.73 |
9.42 |
Average Annual Total Returns | ||||
6-month |
1 Year |
5 Years |
10 Years | |
Trust at NAV (a)(b) |
3.56 % |
13.05 % |
5.17 % |
5.54 % |
Trust at Market Price (a)(b) |
7.85 |
20.12 |
7.34 |
6.64 |
Bloomberg U.S. Corporate High Yield 2% Issuer Capped Index (c) |
2.58 |
10.43 |
3.90 |
4.30 |
(a) |
All returns reflect reinvestment of dividends and/or distributions at actual reinvestment prices. Performance results reflect the Trust’s use of leverage, if any. |
(b) |
The Trust moved from a discount to NAV to a premium during the period, which accounts for the difference between performance based on market price and performance based on NAV. |
(c) |
An unmanaged index comprised of issuers that meet the following criteria: at least $150 million par value outstanding; maximum credit rating of Ba1; at least one year to maturity; and no issuer represents more than 2% of the index. |
PORTFOLIO COMPOSITION | |
Investment Type |
Percent of Total Investments |
Corporate Bonds |
81.3 % |
Floating Rate Loan Interests |
11.5 |
Preferred Securities |
2.9 |
Investment Companies |
2.6 |
Fixed Rate Loan Interests |
1.0 |
Other* |
0.7 |
CREDIT QUALITY ALLOCATION | |
Credit Rating (a) |
Percent of Total Investments |
A |
0.1 % |
BBB/Baa |
3.4 |
BB/Ba |
33.3 |
B |
48.6 |
CCC/Caa |
9.1 |
D |
— (b) |
N/R (c) |
5.5 |
(a) |
For purposes of this report, credit quality ratings shown above reflect the highest rating assigned by either S&P Global Ratings or Moody’s Investors Service, Inc. if ratings differ. These rating agencies are independent, nationally recognized statistical rating organizations and are widely used. Investment grade ratings are credit ratings of BBB/Baa or higher. Below investment grade ratings are credit ratings of BB/Ba or lower. Investments designated N/R are not rated by either rating agency. Unrated investments do not necessarily indicate low credit quality. Credit quality ratings are subject to change. |
(b) |
Rounds to less than 0.1%. |
(c) |
The investment adviser evaluates the credit quality of unrated investments based upon certain factors including, but not limited to, credit ratings for similar investments and financial analysis of sectors and individual investments. Using this approach, the investment adviser has deemed certain of these unrated securities as investment grade quality. As of June 30, 2024, the market value of unrated securities deemed by the investment adviser to be investment grade represents less than 1.0% of total investments. |
* |
Includes one or more investment categories that individually represents less than 1.0% of the Trust ’ s total investments. Please refer to the Consolidated Schedule of Investments for details. |
Symbol on New York Stock Exchange |
BTZ |
Initial Offering Date |
December 27, 2006 |
Current Distribution Rate on Closing Market Price as of June 30, 2024 ($10.71) (a) |
9.40% |
Current Monthly Distribution per Common Share (b) |
$0.083900 |
Current Annualized Distribution per Common Share (b) |
$1.006800 |
Leverage as of June 30, 2024 (c) |
36% |
(a) |
Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate may consist of income, net realized gains and/or a return of capital. Past performance is not an indication of future results. |
(b) |
The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain. |
(c) |
Represents reverse repurchase agreements as a percentage of total managed assets, which is the total assets of the Trust (including any assets attributable to any borrowings) minus the sum of its liabilities (other than borrowings representing financial leverage). Does not reflect derivatives or other instruments that may give rise to economic leverage. For a discussion of leveraging techniques utilized by the Trust, please see The Benefits and Risks of Leveraging and Derivative Financial Instruments. |
06/30/24 |
12/31/23 |
Change |
High |
Low | |
Closing Market Price |
$ 10.71 |
$ 10.32 |
3.78 % |
$ 11.12 |
$ 10.01 |
Net Asset Value |
11.27 |
11.59 |
(2.76 ) |
11.60 |
11.03 |
Average Annual Total Returns | ||||
6-month |
1 Year |
5 Years |
10 Years | |
Trust at NAV (a)(b) |
1.93 % |
10.72 % |
2.97 % |
4.30 % |
Trust at Market Price (a)(b) |
8.78 |
16.31 |
4.37 |
5.10 |
Reference Benchmark (c) |
0.92 |
6.94 |
1.87 |
3.15 |
Bloomberg U.S. Credit Index (d) |
(0.46 ) |
4.42 |
0.54 |
2.21 |
Bloomberg U.S. Corporate High Yield 2% Issuer Capped Index (e) |
2.58 |
10.43 |
3.90 |
4.30 |
Bloomberg USD Capital Securities Index (f) |
1.92 |
8.20 |
2.06 |
3.62 |
(a) |
All returns reflect reinvestment of dividends and/or distributions at actual reinvestment prices. Performance results reflect the Trust’s use of leverage, if any. |
(b) |
The Trust ’ s discount to NAV narrowed during the period, which accounts for the difference between performance based on market price and performance based on NAV. |
(c) |
The Reference Benchmark is comprised of the Bloomberg U.S. Credit Index (50.36%), the Bloomberg U.S. Corporate High Yield 2% Issuer Capped Index (29.93%), and the Bloomberg USD Capital Securities Index (19.71%). |
(d) |
An index that measures the investment grade, U.S. dollar-denominated, fixed-rate, taxable corporate and government related bond markets. It is composed of the U.S. Corporate Index and a non-corporate component that includes foreign agencies, sovereigns, supranationals and local authorities. |
(e) |
An unmanaged index comprised of issuers that meet the following criteria: at least $150 million par value outstanding; maximum credit rating of Ba1; at least one year to maturity; and no issuer represents more than 2% of the index. |
(f) |
An unmanaged index that tracks fixed-rate, investment grade capital securities denominated in USD. |
PORTFOLIO COMPOSITION | |
Investment Type |
Percent of Total Investments (a) |
Corporate Bonds |
72.9 % |
Asset-Backed Securities |
12.0 |
Preferred Securities |
8.1 |
Floating Rate Loan Interests |
4.8 |
Foreign Agency Obligations |
1.3 |
Other* |
0.9 |
CREDIT QUALITY ALLOCATION | |
Credit Rating (b) |
Percent of Total Investments (a) |
AAA/Aaa |
7.4 % |
AA/Aa |
4.2 |
A |
12.3 |
BBB/Baa |
34.9 |
BB/Ba |
20.5 |
B |
16.6 |
CCC/Caa |
2.4 |
N/R (c) |
1.7 |
(a) |
Excludes short-term securities, short investments and options, if any. |
(b) |
For purposes of this report, credit quality ratings shown above reflect the highest rating assigned by either S&P Global Ratings or Moody’s Investors Service, Inc. if ratings differ. These rating agencies are independent, nationally recognized statistical rating organizations and are widely used. Investment grade ratings are credit ratings of BBB/Baa or higher. Below investment grade ratings are credit ratings of BB/Ba or lower. Investments designated N/R are not rated by either rating agency. Unrated investments do not necessarily indicate low credit quality. Credit quality ratings are subject to change. |
(c) |
The investment adviser evaluates the credit quality of unrated investments based upon certain factors including, but not limited to, credit ratings for similar investments and financial analysis of sectors and individual investments. Using this approach, the investment adviser has deemed certain of these unrated securities as investment grade quality. As of June 30, 2024, the market value of unrated securities deemed by the investment adviser to be investment grade represents less than 1.0% of total investments. |
* |
Includes one or more investment categories that individually represents less than 1.0% of the Trust ’ s total investments. Please refer to the Schedule of Investments for details. |
Symbol on New York Stock Exchange |
BGT |
Initial Offering Date |
August 30, 2004 |
Current Distribution Rate on Closing Market Price as of June 30, 2024 ($12.76) (a) |
11.31% |
Current Monthly Distribution per Common Share (b) |
$0.120280 |
Current Annualized Distribution per Common Share (b) |
$1.443360 |
Leverage as of June 30, 2024 (c) |
24% |
(a) |
Current distribution rate on closing market price is calculated by dividing the current annualized distribution per share by the closing market price. The current distribution rate may consist of income, net realized gains and/or a return of capital. Past performance is not an indication of future results. |
(b) |
The distribution rate is not constant and is subject to change. A portion of the distribution may be deemed a return of capital or net realized gain. |
(c) |
Represents bank borrowings outstanding as a percentage of total managed assets, which is the total assets of the Trust (including any assets attributable to borrowings), minus the sum of liabilities (other than borrowings representing financial leverage). Does not reflect derivatives or other instruments that may give rise to economic leverage. For a discussion of leveraging techniques utilized by the Trust, please see The Benefits and Risks of Leveraging and Derivative Financial Instruments. |
06/30/24 |
12/31/23 |
Change |
High |
Low | |
Closing Market Price |
$ |
$ |
3.07 % |
$ |
$ |
Net Asset Value |
(1.24 ) |
Average Annual Total Returns | ||||
6-month |
1 Year |
5 Years |
10 Years | |
Trust at NAV (a)(b) |
4.48 % |
11.91 % |
6.38 % |
5.52 % |
Trust at Market Price (a)(b) |
9.04 |
22.57 |
9.09 |
6.04 |
Morningstar LSTA Leveraged Loan Index (c) |
4.40 |
11.11 |
5.53 |
4.60 |
(a) |
All returns reflect reinvestment of dividends and/or distributions at actual reinvestment prices. Performance results reflect the Trust’s use of leverage, if any. |
(b) |
The Trust moved from a discount to NAV to a premium during the period, which accounts for the difference between performance based on market price and performance based on NAV. |
(c) |
An unmanaged market value-weighted index designed to measure the performance of the U.S. leveraged loan market based upon spreads, interest payments and market weightings subject to a single loan facility weight cap of 2%. |
PORTFOLIO COMPOSITION | |
Investment Type |
Percent of Total Investments (a) |
Floating Rate Loan Interests |
93.5 % |
Asset-Backed Securities |
2.3 |
Investment Companies |
1.7 |
Corporate Bonds |
1.7 |
Other* |
0.8 |
CREDIT QUALITY ALLOCATION | |
Credit Rating (b) |
Percent of Total Investments (a) |
A |
0.1 % |
BBB/Baa |
9.6 |
BB/Ba |
26.0 |
B |
55.4 |
CCC/Caa |
5.0 |
N/R (c) |
3.9 |
(a) |
Excludes short-term securities. |
(b) |
For purposes of this report, credit quality ratings shown above reflect the highest rating assigned by either S&P Global Ratings or Moody’s Investors Service, Inc. if ratings differ. These rating agencies are independent, nationally recognized statistical rating organizations and are widely used. Investment grade ratings are credit ratings of BBB/Baa or higher. Below investment grade ratings are credit ratings of BB/Ba or lower. Investments designated N/R are not rated by either rating agency. Unrated investments do not necessarily indicate low credit quality. Credit quality ratings are subject to change. |
(c) |
The investment adviser evaluates the credit quality of unrated investments based upon certain factors including, but not limited to, credit ratings for similar investments and financial analysis of sectors and individual investments. Using this approach, the investment adviser has deemed certain of these unrated securities as investment grade quality. As of June 30, 2024, the market value of unrated securities deemed by the investment adviser to be investment grade represents less than 1.0% of total investments. |
* |
Includes one or more investment categories that individually represents less than 1.0% of the Trust ’ s total investments. Please refer to the Schedule of Investments for details. |
Security |
Par (000) |
Value | |
Asset-Backed Securities | |||
522 Funding CLO Ltd., Series 2019-4A, Class DR, (3- mo. CME Term SOFR + 3.91%), 9.24%, 04/20/30 (a)(b) |
USD |
600 |
$ 603,068 |
AGL CLO Ltd., Series 2020-3A, Class D, (3-mo. CME Term SOFR + 3.56%), 8.89%, 01/15/33 (a)(b) |
250 |
250,795 | |
AIMCO CLO, Series 2018-BA, Class CRR, (3-mo. CME Term SOFR + 2.40%), 7.73%, 04/16/37 (a)(b) |
650 |
651,549 | |
Apidos CLO XXII, Series 2015-22A, Class CR, (3-mo. CME Term SOFR + 3.21%), 8.54%, 04/20/31 (a)(b) |
250 |
251,057 | |
Apidos CLO XXIV, Series 2016-24A, Class A1AL, (3-mo. CME Term SOFR + 1.21%), 6.54%, 10/20/30 (a)(b) |
463 |
463,229 | |
Apidos CLO XXVI, Series 2017-26A, Class A1AR, (3-mo. CME Term SOFR + 1.16%), 6.49%, 07/18/29 (a)(b) |
467 |
467,146 | |
Apidos CLO XXVII, Series 2017-27A, Class A1R, (3-mo. CME Term SOFR + 1.19%), 6.51%, 07/17/30 (a)(b) |
137 |
136,666 | |
Assurant CLO I Ltd., Series 2017-1A, Class CR, (3-mo. CME Term SOFR + 2.41%), 7.74%, 10/20/34 (a)(b) |
500 |
501,044 | |
Assurant CLO IV Ltd., Series 2019-4A, Class CR, (3-mo. CME Term SOFR + 2.66%), 7.99%, 04/20/30 (a)(b) |
500 |
500,425 | |
Bain Capital Credit CLO Ltd. (a)(b) |
|||
Series 2021-3A, Class D, (3-mo. CME Term SOFR + 3.36%), 8.68%, 07/24/34 |
250 |
246,188 | |
Series 2021-5A, Class B, (3-mo. CME Term SOFR + 1.91%), 7.24%, 10/23/34 |
500 |
500,120 | |
Ballyrock CLO Ltd., Series 2022-21A, Class D, (3-mo. CME Term SOFR + 8.76%), 14.08%, 10/20/35 (a)(b) |
500 |
518,038 | |
Barings CLO Ltd. (a)(b) |
|||
Series 2017-1A, Class D, (3-mo. CME Term SOFR + 3.86%), 9.19%, 07/18/29 |
250 |
251,318 | |
Series 2018-2A, Class A2, (3-mo. CME Term SOFR + 1.81%), 7.14%, 04/15/30 |
1,500 |
1,503,738 | |
Benefit Street Partners CLO VIII Ltd., Series 2015-8A, Class A2R, (3-mo. CME Term SOFR + 1.71%), 7.04%, 01/20/31 (a)(b) |
1,500 |
1,504,443 | |
Benefit Street Partners CLO XIV Ltd., Series 2018-14A, Class B, (3-mo. CME Term SOFR + 1.71%), 7.04%, 04/20/31 (a)(b) |
1,500 |
1,504,406 | |
Birch Grove CLO Ltd., Series 2021-3A, Class D1, (3-mo. CME Term SOFR + 3.46%), 8.79%, 01/19/35 (a)(b) |
250 |
249,251 | |
BlueMountain CLO XXVIII Ltd., Series 2021-28A, Class D, (3-mo. CME Term SOFR + 3.16%), 8.49%, 04/15/34 (a)(b) |
500 |
492,576 | |
Bryant Park Funding Ltd., Series 2024-22A, Class C, (3-mo. CME Term SOFR + 2.60%), 7.91%, 04/15/37 (a)(b) |
1,200 |
1,216,035 | |
Buckhorn Park CLO Ltd., Series 2019-1A, Class AR, (3-mo. CME Term SOFR + 1.38%), 6.71%, 07/18/34 (a)(b) |
2,500 |
2,500,004 | |
Canyon Capital CLO Ltd. (a)(b) |
|||
Series 2016-1A, Class CR, (3-mo. CME Term SOFR + 2.16%), 7.49%, 07/15/31 |
250 |
250,253 | |
Series 2021-2A, Class D, (3-mo. CME Term SOFR + 3.61%), 8.94%, 04/15/34 |
500 |
501,244 | |
Carlyle Global Market Strategies CLO Ltd. (a)(b) |
|||
Series 2013-1A, Class A1RR, (3-mo. CME Term SOFR + 1.21%), 6.53%, 08/14/30 |
74 |
73,624 | |
Series 2013-1A, Class CR, (3-mo. CME Term SOFR + 3.61%), 8.93%, 08/14/30 |
1,000 |
1,000,394 | |
CarVal CLO II Ltd., Series 2019-1A, Class DR, (3-mo. CME Term SOFR + 3.46%), 8.79%, 04/20/32 (a)(b) |
500 |
501,709 | |
CarVal CLO III Ltd., Series 2019-2A, Class E, (3-mo. CME Term SOFR + 6.70%), 12.03%, 07/20/32 (a)(b) |
500 |
493,636 | |
CarVal CLO VC Ltd., Series 2021-2A, Class D, (3-mo. CME Term SOFR + 3.51%), 8.84%, 10/15/34 (a)(b) |
250 |
250,827 |
Security |
Par (000) |
Value | |
Asset-Backed Securities (continued) | |||
CBAM Ltd., Series 2017-1A, Class C, (3-mo. CME Term SOFR + 2.66%), 7.99%, 07/20/30 (a)(b) |
USD |
350 |
$ 350,519 |
Cedar Funding IX CLO Ltd. (a)(b) |
|||
Series 2018-9A, Class A1, (3-mo. CME Term SOFR + 1.24%), 6.57%, 04/20/31 |
206 |
206,827 | |
Series 2018-9A, Class D, (3-mo. CME Term SOFR + 2.86%), 8.19%, 04/20/31 |
250 |
250,029 | |
Cedar Funding VII CLO Ltd., Series 2018-7A, Class A1, (3-mo. CME Term SOFR + 1.26%), 6.59%, 01/20/31 (a)(b) |
403 |
403,286 | |
Cedar Funding X CLO Ltd., Series 2019-10A, Class BR, (3-mo. CME Term SOFR + 1.86%), 7.19%, 10/20/32 (a)(b) |
930 |
929,968 | |
Cedar Funding XIV CLO Ltd., Series 2021-14A, Class B, (3-mo. CME Term SOFR + 1.86%), 7.19%, 07/15/33 (a)(b) |
500 |
499,543 | |
Cedar Funding XV CLO Ltd., Series 2022-15A, Class B, (3-mo. CME Term SOFR + 1.80%), 7.12%, 04/20/35 (a)(b) |
400 |
399,970 | |
CIFC Funding Ltd. (a)(b) |
|||
Series 2013-1A, Class CR, (3-mo. CME Term SOFR + 3.81%), 9.14%, 07/16/30 |
500 |
502,417 | |
Series 2014-2RA, Class B1, (3-mo. CME Term SOFR + 3.06%), 8.38%, 04/24/30 |
750 |
752,327 | |
Series 2014-3A, Class BR2, (3-mo. CME Term SOFR + 2.06%), 7.39%, 10/22/31 |
250 |
251,014 | |
Series 2015-1A, Class ARR, (3-mo. CME Term SOFR + 1.37%), 6.70%, 01/22/31 |
725 |
726,336 | |
Series 2015-3A, Class AR, (3-mo. CME Term SOFR + 1.13%), 6.46%, 04/19/29 |
107 |
107,277 | |
Series 2017-1A, Class CRR, (3-mo. CME Term SOFR + 2.45%), 7.73%, 04/21/37 |
1,000 |
1,011,883 | |
Series 2017-2A, Class AR, (3-mo. CME Term SOFR + 1.21%), 6.54%, 04/20/30 |
363 |
363,432 | |
Series 2017-4A, Class A1R, (3-mo. CME Term SOFR + 1.21%), 6.53%, 10/24/30 |
317 |
317,205 | |
Series 2019-1A, Class DR, (3-mo. CME Term SOFR + 3.36%), 8.69%, 04/20/32 |
500 |
501,718 | |
Series 2020-1A, Class DR, (3-mo. CME Term SOFR + 3.36%), 8.69%, 07/15/36 |
500 |
501,266 | |
Series 2022-7A, Class C, (3-mo. CME Term SOFR + 3.85%), 9.17%, 10/22/35 |
500 |
503,203 | |
Series 2022-7A, Class D, (3-mo. CME Term SOFR + 5.35%), 10.67%, 10/22/35 |
600 |
608,059 | |
CWHEQ Revolving Home Equity Loan Trust, Series 2006-I, Class 1A, (1 mo. Term SOFR + 0.25%), 5.58%, 01/15/37 (a) |
894 |
818,813 | |
Dewolf Park CLO Ltd., Series 2017-1A, Class DR, (3-mo. CME Term SOFR + 3.11%), 8.44%, 10/15/30 (a)(b) |
280 |
280,257 | |
Dryden CLO Ltd. (a)(b) |
|||
Series 2017-53A, Class B, (3-mo. CME Term SOFR + 1.66%), 6.99%, 01/15/31 |
1,320 |
1,321,082 | |
Series 2018-64A, Class D, (3-mo. CME Term SOFR + 2.91%), 8.24%, 04/18/31 |
1,250 |
1,247,252 | |
Series 2022-106A, Class C, (3-mo. CME Term SOFR + 3.90%), 9.23%, 10/15/35 |
500 |
503,091 | |
Dryden Senior Loan Fund (a)(b) |
|||
Series 2015-37A, Class AR, (3-mo. CME Term SOFR + 1.36%), 6.69%, 01/15/31 |
225 |
225,257 | |
Series 2017-50A, Class B, (3-mo. CME Term SOFR + 1.91%), 7.24%, 07/15/30 |
250 |
251,036 | |
Eaton Vance CLO Ltd., Series 2015-1A, Class A2R, (3- mo. CME Term SOFR + 1.51%), 6.84%, 01/20/30 (a)(b) |
1,000 |
1,002,100 |
Security |
Par (000) |
Value | |
Asset-Backed Securities (continued) | |||
EDvestinU Private Education Loan Issue No. 3 LLC, Series 2021-A, Class B, 3.50%, 11/25/50 (b) |
USD |
110 |
$ 87,731 |
Elmwood CLO 21 Ltd., Series 2022-8A, Class CR, (3- mo. CME Term SOFR + 2.70%), 8.02%, 10/20/36 (a)(b) |
500 |
506,430 | |
Elmwood CLO 26 Ltd, Series 2026-1A, Class C, (3-mo. CME Term SOFR + 2.40%), 7.69%, 04/18/37 (a)(b) |
1,300 |
1,312,560 | |
Elmwood CLO V Ltd., Series 2020-2A, Class CR, (3-mo. CME Term SOFR + 2.26%), 7.59%, 10/20/34 (a)(b) |
436 |
436,973 | |
Elmwood CLO VI Ltd. (a)(b) |
|||
Series 2020-3A, Class BR, (3-mo. CME Term SOFR + 1.91%), 7.24%, 10/20/34 |
250 |
251,149 | |
Series 2020-3A, Class BRR, 07/18/37 (c) |
250 |
250,000 | |
Fairstone Financial Issuance Trust I, Series 2020-1A, Class C, 5.16%, 10/20/39 (b) |
CAD |
170 |
116,446 |
Flatiron CLO Ltd., Series 2018-1A, Class A, (3-mo. CME Term SOFR + 1.21%), 6.53%, 04/17/31 (a)(b) |
USD |
944 |
944,384 |
Galaxy CLO Ltd., Series 2023-31A, Class E, (3-mo. CME Term SOFR + 8.43%), 13.76%, 04/15/36 (a)(b) |
350 |
365,216 | |
Galaxy XX CLO Ltd., Series 2015-20A, Class CR, (3-mo. CME Term SOFR + 2.01%), 7.34%, 04/20/31 (a)(b) |
250 |
250,251 | |
Galaxy XXVII CLO Ltd., Series 2018-27A, Class A, (3- mo. CME Term SOFR + 1.28%), 6.61%, 05/16/31 (a)(b) |
1,268 |
1,268,636 | |
Generate CLO Ltd. (a)(b) |
|||
Series 2A, Class AR, (3-mo. CME Term SOFR + 1.41%), 6.74%, 01/22/31 |
176 |
175,978 | |
Series 4A, Class DR, (3-mo. CME Term SOFR + 3.41%), 8.74%, 04/20/32 |
1,500 |
1,500,472 | |
Series 6A, Class DR, (3-mo. CME Term SOFR + 3.76%), 9.09%, 01/22/35 |
750 |
753,518 | |
GoldenTree Loan Management U.S. CLO Ltd. (a)(b) |
|||
Series 12A, Class B, (3-mo. CME Term SOFR + 1.95%), 7.27%, 04/20/34 |
1,000 |
1,004,754 | |
Series 2018-3A, Class B1, (3-mo. CME Term SOFR + 1.81%), 7.14%, 04/20/30 |
250 |
250,478 | |
Series 2019-5A, Class BR, (3-mo. CME Term SOFR + 1.86%), 7.18%, 04/24/31 |
500 |
501,790 | |
Golub Capital Partners CLO Ltd., Series 2021-55A, Class E, (3-mo. CME Term SOFR + 6.82%), 12.15%, 07/20/34 (a)(b) |
250 |
250,583 | |
Gracie Point International Funding LLC, Series 2023-1A, Class D, (90-day Avg SOFR + 4.50%), 9.85%, 09/01/26 (a)(b) |
162 |
164,264 | |
Grippen Park CLO Ltd., Series 2017-1A, Class D, (3-mo. CME Term SOFR + 3.56%), 8.89%, 01/20/30 (a)(b) |
250 |
250,105 | |
Highbridge Loan Management Ltd., Series 3A-2014, Class CR, (3-mo. CME Term SOFR + 3.86%), 9.19%, 07/18/29 (a)(b) |
1,000 |
1,005,346 | |
Litigation Fee Residual, Series 2020-1, Class A, 4.00%, 10/30/27 (d) |
229 |
227,393 | |
Long Beach Mortgage Loan Trust, Series 2006-8, Class 2A4, (1 mo. Term SOFR + 0.59%), 5.94%, 09/25/36 (a) |
5,921 |
1,582,531 | |
Madison Park Funding LIV Ltd., Series 2022-54A, Class E1, (3-mo. CME Term SOFR + 8.95%), 14.27%, 10/21/34 (a)(b) |
263 |
271,702 | |
Madison Park Funding LIX Ltd., Series 2021-59A, Class A1R, (3-mo. CME Term SOFR + 1.50%), 6.83%, 04/18/37 (a)(b) |
1,300 |
1,301,109 |
Security |
Par (000) |
Value | |
Asset-Backed Securities (continued) | |||
Madison Park Funding XLVIII Ltd., Series 2021-48A, Class E, (3-mo. CME Term SOFR + 6.51%), 11.84%, 04/19/33 (a)(b) |
USD |
500 |
$ 501,432 |
Madison Park Funding XVII Ltd., Series 2015-17A, Class DR, (3-mo. CME Term SOFR + 3.86%), 9.19%, 07/21/30 (a)(b) |
1,000 |
1,005,424 | |
Madison Park Funding XXIII Ltd. (a)(b) |
|||
Series 2017-23A, Class AR, (3-mo. CME Term SOFR + 1.23%), 6.56%, 07/27/31 |
958 |
958,809 | |
Series 2017-23A, Class CR, (3-mo. CME Term SOFR + 2.26%), 7.59%, 07/27/31 |
600 |
600,358 | |
Madison Park Funding XXXIV Ltd., Series 2019-34A, Class DR, (3-mo. CME Term SOFR + 3.61%), 8.94%, 04/25/32 (a)(b) |
250 |
251,140 | |
Madison Park Funding XXXVII Ltd., Series 2019-37A, Class BR2, (3-mo. CME Term SOFR + 1.95%), 7.27%, 04/15/37 (a)(b) |
1,000 |
1,005,267 | |
Madison Park Funding XXXVIII Ltd., Series 2021-38A, Class C, (3-mo. CME Term SOFR + 2.16%), 7.48%, 07/17/34 (a)(b) |
250 |
249,452 | |
Marble Point CLO XVII Ltd., Series 2020-1A, Class D, (3-mo. CME Term SOFR + 4.01%), 9.34%, 04/20/33 (a)(b) |
250 |
250,031 | |
Marble Point CLO XXIII Ltd., Series 2021-4A, Class D1, (3-mo. CME Term SOFR + 3.91%), 9.24%, 01/22/35 (a)(b) |
250 |
250,252 | |
Mariner Finance Issuance Trust, Series 2022-AA, Class A, 6.45%, 10/20/37 (b) |
515 |
515,943 | |
Navient Private Education Refi Loan Trust (b) |
|||
Series 2019-D, Class A2A, 3.01%, 12/15/59 |
457 |
432,472 | |
Series 2019-GA, Class A, 2.40%, 10/15/68 |
160 |
150,125 | |
Series 2021-CA, Class A, 1.06%, 10/15/69 |
732 |
644,963 | |
Series 2021-DA, Class C, 3.48%, 04/15/60 |
770 |
682,006 | |
Series 2021-DA, Class D, 4.00%, 04/15/60 |
440 |
400,740 | |
Series 2021-EA, Class A, 0.97%, 12/16/69 |
869 |
755,764 | |
Series 2023-A, Class A, 5.51%, 10/15/71 |
154 |
154,347 | |
Nelnet Student Loan Trust (b) |
|||
Series 2021-A, Class D, 4.93%, 04/20/62 |
460 |
380,386 | |
Series 2021-BA, Class B, 2.68%, 04/20/62 |
1,983 |
1,641,568 | |
Series 2021-CA, Class AFL, (1 mo. Term SOFR + 0.85%), 6.19%, 04/20/62 (a) |
338 |
335,462 | |
Neuberger Berman Loan Advisers CLO Ltd. (a)(b) |
|||
Series 2019-35R, Class CR, (3-mo. CME Term SOFR + 2.30%), 7.63%, 01/19/33 |
1,500 |
1,511,902 | |
Series 2020-37A, Class CR, (3-mo. CME Term SOFR + 2.06%), 7.39%, 07/20/31 |
1,162 |
1,161,792 | |
Neuberger Berman Loan Advisers NBLA CLO Ltd., Series 2022-52A, Class D, (3-mo. CME Term SOFR + 5.75%), 11.07%, 10/24/35 (a)(b) |
568 |
577,563 | |
OCP CLO Ltd. (a)(b) |
|||
Series 16-11R, Class B1R2, (3-mo. CME Term SOFR + 1.95%), 7.27%, 04/26/36 |
500 |
504,043 | |
Series 2015-9A, Class BR2, (3-mo. CME Term SOFR + 1.75%), 7.08%, 01/15/33 |
250 |
250,513 | |
Series 2017-13A, Class A1AR, (3-mo. CME Term SOFR + 1.22%), 6.55%, 07/15/30 |
881 |
881,861 | |
Series 2017-14A, Class A2, (3-mo. CME Term SOFR + 1.76%), 7.09%, 11/20/30 |
1,620 |
1,623,232 | |
Octagon 54 Ltd., Series 2021-1A, Class D, (3-mo. CME Term SOFR + 3.31%), 8.64%, 07/15/34 (a)(b) |
250 |
245,016 |
Security |
Par (000) |
Value | |
Asset-Backed Securities (continued) | |||
Octagon Investment Partners XV Ltd., Series 2013-1A, Class A1RR, (3-mo. CME Term SOFR + 1.23%), 6.56%, 07/19/30 (a)(b) |
USD |
1,981 |
$ 1,982,233 |
Octagon Investment Partners XVII Ltd., Series 2013-1A, Class BR2, (3-mo. CME Term SOFR + 1.66%), 6.99%, 01/25/31 (a)(b) |
500 |
500,520 | |
Octagon Investment Partners XXI Ltd., Series 2014-1A, Class AAR3, (3-mo. CME Term SOFR + 1.26%), 6.58%, 02/14/31 (a)(b) |
239 |
239,082 | |
Octagon Investment Partners XXII Ltd., Series 2014-1A, Class DRR, (3-mo. CME Term SOFR + 3.01%), 8.34%, 01/22/30 (a)(b) |
500 |
500,108 | |
OZLM VIII Ltd., Series 2014-8A, Class CRR, (3-mo. CME Term SOFR + 3.41%), 8.73%, 10/17/29 (a)(b) |
875 |
875,453 | |
OZLM XXI Ltd., Series 2017-21A, Class C, (3-mo. CME Term SOFR + 2.93%), 8.26%, 01/20/31 (a)(b) |
1,000 |
1,001,410 | |
Palmer Square CLO Ltd. (a)(b) |
|||
Series 2013-2A, Class A2R3, (3-mo. CME Term SOFR + 1.76%), 7.08%, 10/17/31 |
250 |
250,468 | |
Series 2015-2A, Class CR2, (3-mo. CME Term SOFR + 3.01%), 8.34%, 07/20/30 |
250 |
250,526 | |
Series 2020-3ARR, Class A1R2, (3-mo. CME Term SOFR + 1.65%), 6.97%, 11/15/36 |
250 |
251,780 | |
Series 2020-3ARR, Class A2R2, (3-mo. CME Term SOFR + 2.30%), 7.62%, 11/15/36 |
250 |
254,063 | |
Series 2022-4A, Class C, (3-mo. CME Term SOFR + 4.00%), 9.32%, 10/20/35 |
1,000 |
1,012,223 | |
Palmer Square Loan Funding Ltd. (a)(b) |
|||
Series 2021-1A, Class A1, (3-mo. CME Term SOFR + 1.16%), 6.49%, 04/20/29 |
28 |
28,165 | |
Series 2021-2A, Class A1, (3-mo. CME Term SOFR + 1.06%), 6.39%, 05/20/29 |
55 |
54,697 | |
Series 2021-3A, Class A1, (3-mo. CME Term SOFR + 1.06%), 6.39%, 07/20/29 |
254 |
254,005 | |
Park Avenue Institutional Advisers CLO Ltd., Series 2017- 1A, Class DR, (3-mo. CME Term SOFR + 7.07%), 12.39%, 02/14/34 (a)(b) |
1,300 |
1,251,765 | |
Prodigy Finance DAC, Series 2021-1A, Class C, (1 mo. Term SOFR + 3.86%), 9.21%, 07/25/51 (a)(b) |
68 |
69,000 | |
Rad CLO Ltd., Series 2019-3A, Class DR, (3-mo. CME Term SOFR + 3.01%), 8.34%, 04/15/32 (a)(b) |
400 |
400,407 | |
Regatta XI Funding Ltd., Series 2018-1A, Class D, (3- mo. CME Term SOFR + 3.11%), 8.43%, 07/17/31 (a)(b) |
370 |
370,003 | |
Regatta XVIII Funding Ltd., Series 2021-1A, Class B, (3-mo. CME Term SOFR + 1.71%), 7.04%, 01/15/34 (a)(b) |
850 |
851,970 | |
Regional Management Issuance Trust, Series 2022-2B, Class A, 7.10%, 11/17/32 (b) |
200 |
201,411 | |
Republic Finance Issuance Trust, Series 2020-A, Class C, 4.05%, 11/20/30 (b) |
240 |
232,784 | |
Romark CLO Ltd., Series 2017-1A, Class B, (3-mo. CME Term SOFR + 2.41%), 7.74%, 10/23/30 (a)(b) |
500 |
500,075 | |
Shackleton CLO Ltd., Series 2015-7RA, Class C, (3-mo. CME Term SOFR + 2.61%), 7.94%, 07/15/31 (a)(b) |
250 |
250,268 | |
Signal Peak CLO Ltd., Series 2017-4A, Class XR, (3-mo. CME Term SOFR + 1.21%), 6.54%, 10/26/34 (a)(b) |
900 |
900,140 | |
SMB Private Education Loan Trust (b) |
|||
Series 2019-A, Class A2A, 3.44%, 07/15/36 |
1,014 |
978,507 | |
Series 2019-B, Class A2A, 2.84%, 06/15/37 |
211 |
201,140 | |
Series 2021-A, Class A2B, 1.59%, 01/15/53 |
325 |
290,529 | |
Series 2021-A, Class B, 2.31%, 01/15/53 |
221 |
207,381 | |
Series 2021-C, Class C, 3.00%, 01/15/53 |
127 |
106,456 |
Security |
Par (000) |
Value | |
Asset-Backed Securities (continued) | |||
SMB Private Education Loan Trust (b) (continued) |
|||
Series 2021-C, Class D, 3.93%, 01/15/53 |
USD |
86 |
$ 76,260 |
Series 2021-D, Class A1A, 1.34%, 03/17/53 |
990 |
895,787 | |
Series 2022-C, Class A1A, 4.48%, 05/16/50 |
315 |
305,980 | |
Series 2023-B, Class A1B, (30-day Avg SOFR + 1.80%), 7.13%, 10/16/56 (a) |
207 |
211,780 | |
Series 2023-C, Class A1A, 5.67%, 11/15/52 |
1,473 |
1,486,585 | |
Sterling COOFS Trust (d) |
|||
Series 2004-1, Class A, 2.00%, 04/15/29 |
700 |
7,002 | |
Series 2004-2, Class Note, 2.08%, 03/30/30 (b) |
402 |
4,024 | |
Structured Asset Securities Corp. Pass-Through Certificates, Series 2002-AL1, Class A2, 3.45%, 02/25/32 |
23 |
20,337 | |
Subway Funding LLC, Series 2024-1A, Class A2I, 6.03%, 07/30/54 (b) |
295 |
297,623 | |
Symphony CLO XXXII Ltd., Series 2022-32A, Class B, (3-mo. CME Term SOFR + 1.85%), 7.18%, 04/23/35 (a)(b) |
600 |
600,491 | |
TCI-Symphony CLO Ltd., Series 2017-1A, Class AR, (3-mo. CME Term SOFR + 1.19%), 6.52%, 07/15/30 (a)(b) |
391 |
391,416 | |
TCW CLO Ltd., Series 2020-1A, Class DRR, (3-mo. CME Term SOFR + 3.66%), 8.99%, 04/20/34 (a)(b) |
250 |
250,180 | |
TICP CLO IX Ltd., Series 2017-9A, Class D, (3-mo. CME Term SOFR + 3.16%), 8.49%, 01/20/31 (a)(b) |
500 |
500,432 | |
TICP CLO XV Ltd., Series 2020-15A, Class D, (3-mo. CME Term SOFR + 3.41%), 8.74%, 04/20/33 (a)(b) |
250 |
250,655 | |
Trestles CLO Ltd. (a)(b) |
|||
Series 2017-1A, Class B1R, (3-mo. CME Term SOFR + 2.01%), 7.34%, 04/25/32 |
1,750 |
1,747,734 | |
Series 2017-1A, Class CR, (3-mo. CME Term SOFR + 3.16%), 8.49%, 04/25/32 |
250 |
250,352 | |
Series 2017-1A, Class CRR, 07/25/37 (c) |
1,750 |
1,750,000 | |
Series 2017-1A, Class D1RR, 07/25/37 (c) |
250 |
250,000 | |
Trimaran CAVU Ltd. (a)(b) |
|||
Series 2019-2A, Class C, (3-mo. CME Term SOFR + 4.98%), 10.31%, 11/26/32 |
500 |
500,420 | |
Series 2021-2A, Class D1, (3-mo. CME Term SOFR + 3.51%), 8.84%, 10/25/34 |
500 |
499,969 | |
Series 2022-1, Class E, (3-mo. CME Term SOFR + 9.08%), 14.40%, 10/22/35 |
500 |
513,483 | |
Series 2022-2A, Class D, (3-mo. CME Term SOFR + 6.12%), 11.44%, 01/20/36 |
400 |
408,715 | |
Series 2023-1, Class E, (3-mo. CME Term SOFR + 8.94%), 14.26%, 07/20/36 |
500 |
521,753 | |
Unique Pub Finance Co. PLC, Series 02, Class N, 6.46%, 03/30/32 (e) |
GBP |
6 |
7,856 |
Voya CLO Ltd. (a)(b) |
|||
Series 2014-2A, Class A1RR, (3-mo. CME Term SOFR + 1.28%), 6.60%, 04/17/30 |
USD |
97 |
97,118 |
Series 2017-2A, Class A2AR, (3-mo. CME Term SOFR + 1.91%), 7.24%, 06/07/30 |
250 |
250,187 | |
Series 2017-3A, Class A1R, (3-mo. CME Term SOFR + 1.30%), 6.63%, 04/20/34 |
1,900 |
1,900,499 | |
Series 2018-2A, Class A2, (3-mo. CME Term SOFR + 1.51%), 6.84%, 07/15/31 |
1,000 |
1,000,500 | |
Whetstone Park CLO Ltd., Series 2021-1A, Class B1, (3-mo. CME Term SOFR + 1.86%), 7.19%, 01/20/35 (a)(b) |
725 |
725,092 | |
Whitebox CLO I Ltd., Series 2019-1A, Class D1RR, (3- mo. CME Term SOFR + 3.10%), 8.44%, 07/24/36 (a)(b) |
500 |
500,000 |
Security |
Par (000) |
Value | |
Asset-Backed Securities (continued) | |||
Whitebox CLO II Ltd., Series 2020-2A, Class DR, (3-mo. CME Term SOFR + 3.61%), 8.93%, 10/24/34 (a)(b) |
USD |
500 |
$ 501,526 |
Whitebox CLO III Ltd. (a)(b) |
|||
Series 2021-3A, Class D, (3-mo. CME Term SOFR + 3.61%), 8.94%, 10/15/34 |
250 |
250,769 | |
Series 2021-3A, Class E, (3-mo. CME Term SOFR + 7.11%), 12.44%, 10/15/34 |
250 |
251,020 | |
Total Asset-Backed Securities — 17.0% (Cost: $97,182,958) |
96,661,726 | ||
Corporate Bonds | |||
Advertising Agencies (b) — 0.1% | |||
Neptune Bidco U.S., Inc., 9.29%, 04/15/29 |
325 |
311,927 | |
Stagwell Global LLC, 5.63%, 08/15/29 |
69 |
63,729 | |
375,656 | |||
Aerospace & Defense — 3.1% | |||
AAR Escrow Issuer LLC, 6.75%, 03/15/29 (b) |
170 |
173,295 | |
Boeing Co. |
|||
6.30%, 05/01/29 (b) |
1,840 |
1,865,871 | |
2.95%, 02/01/30 |
800 |
684,902 | |
3.60%, 05/01/34 |
550 |
442,509 | |
6.53%, 05/01/34 (b)(f) |
435 |
445,396 | |
Bombardier, Inc. (b) |
|||
7.88%, 04/15/27 |
69 |
69,176 | |
6.00%, 02/15/28 (f) |
261 |
257,997 | |
7.50%, 02/01/29 |
3 |
3,109 | |
8.75%, 11/15/30 (f) |
294 |
317,750 | |
7.25%, 07/01/31 |
83 |
85,218 | |
7.00%, 06/01/32 |
136 |
137,889 | |
7.45%, 05/01/34 |
100 |
112,324 | |
Embraer Netherlands Finance BV, 7.00%, 07/28/30 (b) |
263 |
274,424 | |
F-Brasile SpA/F-Brasile U.S. LLC, Series XR, 7.38%, 08/15/26 (b)(f) |
200 |
198,000 | |
General Electric Co., 6.15%, 08/07/37 |
2,150 |
2,248,318 | |
L3Harris Technologies, Inc. |
|||
2.90%, 12/15/29 |
1,200 |
1,070,268 | |
1.80%, 01/15/31 |
300 |
242,715 | |
Lockheed Martin Corp., 3.80%, 03/01/45 |
800 |
637,707 | |
Northrop Grumman Corp. |
|||
4.70%, 03/15/33 |
400 |
385,901 | |
3.85%, 04/15/45 |
850 |
662,253 | |
RTX Corp. |
|||
2.38%, 03/15/32 |
1,000 |
819,631 | |
5.15%, 02/27/33 |
900 |
890,652 | |
4.50%, 06/01/42 |
300 |
259,833 | |
Spirit AeroSystems, Inc. (b) |
|||
9.38%, 11/30/29 |
296 |
318,685 | |
9.75%, 11/15/30 |
279 |
307,769 | |
TransDigm, Inc. (b) |
|||
6.75%, 08/15/28 |
614 |
621,506 | |
6.38%, 03/01/29 (f) |
1,225 |
1,231,178 | |
7.13%, 12/01/31 |
466 |
480,156 | |
6.63%, 03/01/32 (f) |
1,599 |
1,615,085 | |
Triumph Group, Inc., 9.00%, 03/15/28 (b) |
476 |
498,962 | |
17,358,479 |
Security |
Par (000) |
Value | |
Air Freight & Logistics — 0.2% | |||
FedEx Corp., 4.75%, 11/15/45 (f) |
USD |
1,250 |
$ 1,077,635 |
Rand Parent LLC, 8.50%, 02/15/30 (b) |
15 |
15,186 | |
1,092,821 | |||
Automobile Components — 0.6% | |||
Aptiv PLC, 4.40%, 10/01/46 |
465 |
362,844 | |
Champions Financing, Inc., 8.75%, 02/15/29 (b)(f) |
217 |
222,528 | |
Clarios Global LP/Clarios U.S. Finance Co. |
|||
4.38%, 05/15/26 (e) |
EUR |
200 |
213,119 |
8.50%, 05/15/27 (b)(f) |
USD |
1,287 |
1,294,260 |
6.75%, 05/15/28 (b) |
340 |
344,098 | |
Dana Financing Luxembourg SARL, 8.50%, 07/15/31 (e) |
EUR |
100 |
116,587 |
Forvia SE, 3.75%, 06/15/28 (e) |
100 |
103,080 | |
Garrett Motion Holdings, Inc./Garrett LX I SARL, 7.75%, 05/31/32 (b) |
USD |
262 |
265,517 |
Goodyear Tire & Rubber Co., 5.63%, 04/30/33 |
81 |
73,218 | |
Phinia, Inc., 6.75%, 04/15/29 (b) |
80 |
81,187 | |
Schaeffler AG, 4.75%, 08/14/29 (e) |
EUR |
100 |
107,791 |
Tenneco, Inc., 8.00%, 11/17/28 (b) |
USD |
39 |
35,503 |
ZF Finance GmbH, 3.75%, 09/21/28 (e) |
EUR |
100 |
103,620 |
3,323,352 | |||
Automobiles — 0.9% | |||
Asbury Automotive Group, Inc., 4.50%, 03/01/28 |
USD |
10 |
9,475 |
Aston Martin Capital Holdings Ltd., 10.38%, 03/31/29 (e) |
GBP |
100 |
125,462 |
Carvana Co. (b)(g) |